ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,343Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 2456

$995K Total Retail Price of All Prescriptions

Rank: 36 out of 2456

527 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 527 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 527 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

4% of this provider’s 8,843 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 587 394 1 2
LISINOPRIL 533 450 2 1
LEVOTHYROXINE SODIUM 438 302 3 4
TRAZODONE HCL 366 165 4 17
OMEPRAZOLE 354 218 5 3
ATENOLOL 340 287 6 6
DIVALPROEX SODIUM 320 140 7 51
WARFARIN SODIUM 312 249 8 9
METOPROLOL TARTRATE 283 220 9 10
METFORMIN HCL 274 184 10 11
QUETIAPINE FUMARATE 259 110 11 47
RISPERIDONE 240 131 12 50
HYDROCHLOROTHIAZIDE 236 205 13 7
FUROSEMIDE 235 197 14 8
AMLODIPINE BESYLATE 235 222 14 5
ATORVASTATIN CALCIUM 217 184 16 12
RANITIDINE HCL 204 121 17 31
GABAPENTIN 191 112 18 16
CITALOPRAM HBR 190 156 19 14
HYDROCODONE-ACETAMINOPHEN 177 129 S3 20 20
BENZTROPINE MESYLATE 174 102 R 21 126
ABILIFY 155 57 22 95
CLOZAPINE 144 31 23 75
IBUPROFEN 134 87 24 52
SERTRALINE HCL 130 54 25 21
OXYCODONE-ACETAMINOPHEN 120 55 S2 26 35
OLANZAPINE 119 82 27 57
PROAIR HFA 119 82 27 22
LORAZEPAM 114 106 29 67
ADVAIR DISKUS 111 82 30 36
OXYBUTYNIN CHLORIDE ER 110 35 31 94
LANTUS 109 81 32 44
TAMSULOSIN HCL 104 74 33 32
MIRTAZAPINE 104 62 33 29
VENLAFAXINE HCL ER 99 78 35 92
SEROQUEL 99 38 35 102
DIVALPROEX SODIUM ER 93 20 37 178
GLYBURIDE 93 61 R 37 40
CYCLOBENZAPRINE HCL 92 32 R 39 77
AMITRIPTYLINE HCL 90 61 R 40 83
GLIPIZIDE 89 86 41 46
FLUOXETINE HCL 85 42 42 45
CYMBALTA 82 24 43 65
HALOPERIDOL 78 29 44 137
ALENDRONATE SODIUM 76 57 45 19
LIDODERM 65 21 46 58
DONEPEZIL HCL 62 51 47 23
CLOPIDOGREL 62 47 47 55
CIPROFLOXACIN HCL 60 47 49 87
LEVETIRACETAM 58 19 50 90
ALLOPURINOL 54 54 51 27
IPRATROPIUM-ALBUTEROL 53 34 52 85
VERAPAMIL ER 53 50 52 91
PROPRANOLOL HCL 52 37 54 108
PLAVIX 52 36 54 79
SPIRIVA 51 33 56 43
NOVOLOG 51 16 56 100
POTASSIUM CHLORIDE 50 36 58 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.